bluebird bio, Inc. Common Stock

Bluebird Bio has amended its definitive agreement with Carlyle and SK Capital Partners, allowing shareholders to choose between $5 cash or $3 plus a $6.84 contingent value right (CVR) per share. The transaction is expected to close promptly after receiving all regulatory approvals.

Related tickers: BLUE, CG.

M&A activity in the US is stagnant, but it is booming in other regions like Canada, Europe, and Australia. Several companies, including Totalmobile, TIP Group, and Plenitude, are reportedly considering or undergoing sales processes.

Related tickers: AMZN, BIP, BIPH, BIPI, BIPJ, BIPpA, BIPpB, BLUE, BX.